BIT BIO
LIVE

Serial Number

79284412

Owner

Bit Bio Limited

Attorney

Katrina G. Hull

Filing Date

Feb 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BIT BIO Trademark

Serial Number: 79284412 • Registration: 6324834

BIT BIO is a trademark filed by Bit Bio Limited on February 10, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 29 (Meats & Processed Foods). The application is currently registered and active.

Owner Contact Info

Bit Bio Limited (21 trademarks)

Pioneer House,
Cambridge, Cambridgeshire CB24 9NL , GB

Entity Type: 99

Trademark Details

Filing Date

February 10, 2020

Registration Date

April 20, 2021

Published for Opposition

February 2, 2021

Goods & Services

Pharmaceuticals in the nature of cell therapeutics for medical, therapeutic or clinical use; genetically or otherwise modified cells; cells which are propagated, cultivated and expanded in bioreactors; cells for the purpose of tissue regeneration for medical or clinical use; living cells for medical use; cells for medical use; biological preparations for medical use; diagnostic preparations for medical and veterinary purposes; cell preparations for medical use in drug screening; cell preparations for genetic testing and screening for medical purposes or clinical use; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical or diagnostic use; tissue culture media growth factors in the nature of cell growth, cell growth media, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells all for medical or clinical use; cell separation reagents for medical or clinical use; dietary supplements; protein supplements; nutrition supplements

Biotechnology research; scientific testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; stem cell research; synthetic biology services, namely, biological research; stem cell biology services, namely, biological research; scientific services for scientific, research, clinical, therapeutic and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells; research and development in relation to genetic testing, screening; research and development in relation to drug screening; cell separation technology services for scientific, research, clinical, therapeutic and manufacturing purposes; cell separation research services for scientific, research, clinical, therapeutic and manufacturing purposes; consultancy relating to biotechnology; scientific and research consultancy relating to drug screening; scientific and research consultancy relating to genetic screening; scientific and research consultancy relating to cell therapy; laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, synthetic biology and manufacturing; research on food; research and development in the field of animal cells cultivated within bioreactors; research in the reduction of carbon emissions

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, stem cells for scientific purposes, stem cells other than for medical or veterinary purposes, skeletal myocytes for research purposes, cortical neurons for research purposes, biological tissue for research and scientific purposes, biological tissue cultures other than for medical or veterinary purposes, cultures of cell media other than for medical or veterinary use, chemical reagents for use in biotechnology, other than for medical or veterinary use, nutritive agents for processing living cells other than for medical use, semi-processed natural proteins for manufacturing food, proteins for use in the manufacture of food products, proteins for use in recombinant DNA technology other than for medical use, cell therapeutics, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, living cells for medical use, cells for medical use, biological preparations for medical use, diagnostic preparations for medical and/or veterinary purposes, cell preparations for drug screening, cell preparations for genetic testing, screening, stem cells for medical purposes, stem cells for veterinary purposes, cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, cell separation reagents, magnetic cell separation equipment, dietary supplements, protein supplements, nutrition supplements, meat, meat substitutes, tissue engineered meat, synthetic meat, cultured meat, laboratory-grown meat and fish, not live

Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; bioreactors for biomanufacturing; bioreactors for research use; bioreactor for cell culturing; bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; magnetic cell separation equipment, namely, apparatus for the separation of cell populations for medical or clinical use

Meat; meat substitutes; tissue engineered meat; synthetic meat; cultured meat; laboratory-grown meat; fish, not live

Stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; skeletal myocytes for research purposes; cortical neurons for research purposes; biological human tissue for research and scientific purposes; biological tissue cultures other than for medical or veterinary purposes; cultures of cell media for scientific or research use; chemical reagents for use in biotechnology, other than for medical or veterinary use; nutritive agents for processing living cells other than for medical use; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in recombinant DNA technology other than for medical use; cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical research use

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 20, 2026 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 8, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Feb 14, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
May 4, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 14, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 28, 2021 FICS
FINAL DISPOSITION PROCESSED
Jul 28, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 20, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 20, 2021 R.PR
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Feb 3, 2021 CREV
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Feb 2, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Jan 30, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 13, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 13, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 13, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 31, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 16, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 16, 2020 TROA
CORRECTION TRANSACTION RECEIVED FROM IB
Dec 12, 2020 CRCV
REFUSAL PROCESSED BY IB
Jul 10, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 25, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jun 25, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 23, 2020 RFCR
NON-FINAL ACTION WRITTEN
May 22, 2020 CNRT
ASSIGNED TO EXAMINER
May 11, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
May 5, 2020 MAFR
ASSIGNED TO EXAMINER
May 1, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 30, 2020 REPR